Nuvasive (Nasdaq:NUVA) reported second-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The San Diego–based spine surgery tech company yesterday evening reported losses of $893,000, or 2¢ per share, on sales of $310.5 million for the three months ended June 30, 2022 — versus a profit of $1.799 million, or […]
Owens & Minor shares down on revised outlook
Owens & Minor (NYSE:OMI) today posted Q2 results that matched the overall consensus on Wall Street, though it revised its outlook amid macroeconomic headwinds. The Richmond, Virginia–based healthcare products and services giant reported profits of $28.6 million, or 37¢ per share, on sales of $2.5 billion for the three months ended June 30 for a […]
SeaSpine posts mixed-bag Q2 results, raises guidance for fiscal 2022
SeaSpine (NSDQ:SPNE) posted second-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Carlsbad, California–based spine treatment tech company reported losses of $13.9 million, or -38¢ per share, on sales of $56.3 million for the three months ended June 30, 2022, nearly triple the losses versus the same quarter a […]
Cardiovascular Systems misses Wall Street estimates in Q4, anticipates revenue growth in FY 2023
Cardiovascular Systems (NSDQ:CSII) today posted fourth-quarter results that missed the overall consensus on Wall Street. The St. Paul, Minnesota-based heart device company reported losses of $9.69 million, or -25¢ per share, on sales of $62.5 million for the three months ended June 30, for a bottom-line loss of 83.3% on sales loss of 11.96% compared with Q4 […]
Medline to distribute Visby handheld STI test to healthcare orgs
Medline announced it is supplying Visby Medical Sexual Health Click handheld PCR test to healthcare organizations. The point-of-care device for sexually transmitted infections (STIs) is an all-in-one unit that is FDA cleared to provide a diagnosis in under 30 minutes. The company will provide the tests to urgent care centers, student health centers, women’s health […]
Conmed to acquire bioinductive scaffold startup Biorez
Conmed (NYSE:CNMD) this week announced a definitive agreement to acquire medtech startup Biorez. The company will acquire Biorez to enhance its sports medicine soft tissue healing portfolio. It plans to acquire the company on a cash-free, debt-free basis, for a cash consideration of $85 million at closing with up to an additional $165 million in growth-based […]
Tactile Systems revenue beats Wall Street estimates in Q2
Tactile Systems (NSDQ: TCMD) this week posted second-quarter results that included Street-beasting revenues. The Minneapolis-based maker of at-home therapies for underserved, chronic conditions reported losses of $4.6 million, or -23¢ per share, on sales of $59.6 million for the three months ended June 30, for a sales growth of 16.81% compared with Q2 2021. Adjusted […]
TransMedics grows sales 151% in Q2
TransMedics (NSDQ:TMDX) this week posted second-quarter financial results that beat the revenue consensus on Wall Street and missed earnings estimates. The Andover, Massachusetts-based organ preservation tech company reported losses of $11.5 million, or -41¢ per share, on sales of $20.5 million for the three months ended June 30, for a bottom-line loss of 8% on sales […]
Merit Medical more than doubles profits in Q2, raises guidance
Merit Medical (Nasdaq:MMSI) posted second-quarter results this week that exceeded the consensus forecast on Wall Street. The South Jordan, Utah-based disposable medical devices maker reported profits of $15.3 million, or 27¢ per share, on sales of $294.98 million for the three months ended June 30, for a bottom-line gain of 211.2% on sales growth of […]
Teleflex lowers guidance on mixed bag Q2 results
Teleflex (NYSE:TFX) posted second-quarter results today that missed the revenue consensus on Wall Street and cut its outlook for the rest of the year. Shares in TFX were down 10.40% to $238.80 apiece in mid-morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1.1%. The […]
Integer boosts 2022 revenue projections, cuts earnings outlook
Integer (NYSE:ITGR) posted second-quarter results today that beat the overall consensus forecast on Wall Street. The Plano, Texas–based medical device outsource manufacturer reported profits of $20.8 million, or 62¢ per share, on sales of $350 million for the three months ended July 1, for a bottom-line slide of 29.2% on sales growth of 12.2% compared with […]